Primary treatment | Combination | PoTS UK | PoTS clinic |
---|---|---|---|
No treatment | 20 (24%) | 17 (32.5%) | |
β-blocker | Alone | 15 (18%) | 10 (19%) |
Plus midodrine | 4 (5%) | 2 (4%) | |
Ivabradine | Alone | 4 (5%) | 7 (13%) |
Midodrine | 0 | 2 (4%) | |
Fludrocortisone | 1 (1%) | 1 (2%) | |
Sertraline | 1 (1%) | 0 | |
Duloxetine | 1 (1%) | 0 | |
β-blocker | 0 | 1 (2%) | |
Diltiazem | Alone | 1 (2%) | |
Fludrocortisone | 1 (1%) | 0 | |
Midodrine | 0 | 1 (2%) | |
Verapamil | Alone | 0 | 1 (2%) |
Fludrocortisone | Alone | 5 (6%) | 2 (4%) |
β-blocker | 5 (6%) | 2 (4%) | |
Midodrine | 5 (6%) | 0 | |
Midodrine | Alone | 12 (14%) | 4 (7.5%) |
Buproprion | 1 (1%) | 0 | |
Octretide | + midodrine + fludro | 2 (2.5%) | 0 |
Pregabalin | 1 (1%) | 0 | |
Clonazepam | 1 (1%) | 0 | |
Antidepressant | 3 (4%) | 0 | |
Salt only | 2 (2.5%) | 1 (2%) |